In this video, Daniel von Allmen, MD, from Cincinnati Children's Hospital, discusses when a clinician should choose surgery over systemic therapy for their pediatric patient with inflammatory bowel...
Bruce Given, MD, discusses alpha-1 antitrypsin deficiency (AATD) treatment methods, including enzyme therapy and gene therapy, and the hope that advancements in replacement therapy will improve treatments...
Victor Tapson, MD, and Summit Co-Chair Edward Shahady, MD, discuss identification, assessment and coordinated management of PAH across the care continuum.
Michael Banks, MD, talks about how 2016 Medicaid criteria has allowed for increased access to direct-acting antiviral therapies among patients with hepatitis C virus for whom the costs of the treatments...
